Low-coverage whole-genome sequencing of cancer and healthy plasma circulating DNA
Plasma samples from patients with melanoma (stage II/III/IV) and breast cancer (stage IV) as well as healthy individuals were subjected to low-coverage whole-genome sequencing (less than 10x average depth). This dataset contains raw fastq files from 39 breast cancer, 127 melanoma and 42 healthy control plasma samples.
- 208 samples
- DAC: EGAC00001003451
- Technology: Illumina NovaSeq 6000
All requests to access data will be assessed by the Peter MacCallum Cancer Centre Data Governance Office. Emails may be directed to dgo@petermac.org.
Please email dgo@petermac.org to obtain the detailed policy regarding data access.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
Study ID | Study Title | Study Type |
---|---|---|
Cancer Genomics |